• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE Back to Search Results
Catalog Number UNKNOWN
Device Problem Migration (4003)
Patient Problems Obstruction/Occlusion (2422); No Information (3190); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/05/2020
Event Type  Injury  
Manufacturer Narrative
510(k) number: k163468.The investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event Description
Zhou-2020 (evo-c): safety and efficacy of through-the-scope placement of colonic self-expandable metal stents without fluoroscopic guidance: a retrospective cohort study.Retrospective study carried out in patients undergoing endoscopic sems insertion with or without fluoroscopic guidance for malignant large-bowel obstruction in a single tertiary medical center.Sems placement was performed using a 1-channel endoscope with working channel = 3.7 mm diameter (cf-h260; olympus co., tokyo, japan).The stenting procedures are briefly summarized as follows: in the f group, a hydrophilic guidewire and a biliary dilation catheter (cook medical, winston-salem, nc) were inserted through the stricture.Then, the guidewire was removed and a water-soluble contrast agent was injected through catheter to insure proper entry into the proximal lumen and to evaluate the length of the stenosis under fluoroscopy.Then, after the guidewire was reinserted and the dilation catheter was withdrawn, the stent was advanced through the endoscope across the lesion and deployed under endoscopic and fluoroscopic guidance.In the nf group, procedures were otherwise the same as in f group, except that fluoroscopy was not used and contrast agent injection was omitted (off-label use).Guidewire and dilation catheter were considered across the stricture when they were easily advanced without resistance.When resistance was felt, the guidewire tip direction was adjusted.Insertion was retried until easy advance of at least 10 cm of both the guidewire and the catheter.The stent was deployed only under endoscopic monitoring.Stent length must allow for at least 2 cm of additional exposure to each end of the stricture.If one stent was not long enough to cover the obstruction, a second stent was used and at least 3 cm of overlap was obtained.1 patient in the fluoroscopy group experienced stent migration.Stent migration occurred 1 week after stent placement, and this was amended by endoscopic stent reinsertion.
 
Manufacturer Narrative
510(k) number: k163468.Device evaluation: the colonic devices involved in this complaint was not returned to cirl for evaluation.With the information provided, a document based investigation will be complete.This file was created from the attached journal article.Reference "(b)(4)" this file 320500 was opened to investigate stent migration and intervention.Lab evaluation: n/a.Documents review including ifu review: as the rpn and lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution evo colonic devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.As the evo colonic devices from unknown lot number, a review of the relevant manufacturing records cannot be conducted.As per the instructions for use, ifu (b)(4), which accompanies this device it informs the user about the potential complications "additional contraindications include, but are not limited to : "stent misplacement and/or migration¿ there is no evidence to suggest that the customer did not follow the instructions for use.Image review: n/a.Root cause review: a definitive root cause could not be determined from the available information.A possible root cause could be attributed the patient¿s pre-existing condition.From the information provided it is known that the patient had malignant colorectal cancer.Summary: complaint is confirmed based on the customers testimony.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation.
 
Event Description
Supplemental report is being submitted due to a correction to the completed investigation annex codes investigation findings code (annex c).C13 - operational problem identified updated to c0701 - device migration.
 
Manufacturer Narrative
510(k) number: k163468.Device evaluation: the colonic devices involved in this complaint was not returned to cirl for evaluation.With the information provided, a document based investigation will be complete.This file was created from the attached journal article.Reference (b)(4).This file 320500 (3001845648-2021-00137) was opened to investigate stent migration and intervention.Documents review including ifu review: as the rpn and lot number of the complaint stents are unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution evo colonic devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.As the evo colonic devices from unknown lot number, a review of the relevant manufacturing records cannot be conducted.As per the instructions for use, ifu0052-11, which accompanies this device it informs the user about the potential complications "additional contraindications include, but are not limited to : "stent misplacement and/or migration¿ there is no evidence to suggest that the customer did not follow the instructions for use.Root cause review: a definitive root cause could not be determined from the available information.A possible root cause could be attributed the patient¿s pre-existing condition.From the information provided it is known that the patient had malignant colorectal cancer.Summary: complaint is confirmed based on the customers testimony.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED
Type of Device
MQR STENT, COLONIC METALLIC EXPANDABLE
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND
holstein campus kiel
arnold- keller str- 3
limerick
Manufacturer Contact
sinead o'leary
holstein campus kiel
arnold- keller str- 3
limerick 
MDR Report Key11345524
MDR Text Key241074546
Report Number3001845648-2021-00137
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 08/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/05/2020
Event Location Hospital
Date Manufacturer Received01/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient SexMale
-
-